The anticancer properties of dietary polyphenols and its relation with apoptosis

Current Pharmaceutical Design

Volumn 16, Issue 1, 2010, Pages 114-134

  Fresco, P ^a   Borges, F ^a,b   Marques, M P M ^b,c   Diniz, C ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Apoptosis; Cancer; Chemoprevention; Diet; Polyphenolic compunds

Indexed keywords

POLYPHENOL;

ANIMAL MODEL; APOPTOSIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CHEMOTHERAPY; DIETARY INTAKE; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL PROLIFERATION; DIET; FLAVONOIDS; HUMANS; NEOPLASMS; PHENOLS; SIGNAL TRANSDUCTION;

EID: 77949474775     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210789941856     Document Type: Review

References (307)

1. Stewart BW, Kleihues P. Eds. World Cancer Report, Internacional Agency for Research on Cancer, World Health Organization, 2003 (ISBN 9283204115).
2. Everitt AV, Hilmer SN, Brand-Miller JC, Jamieson HA, Truswell AS, Sharma AP, et al. Dietary approaches that delay age-related diseases. Clin IntervAging 2006; 1: 11-31.
3. Chiuve SE, Willet WC. The 2005 Food Guide Pyramid: an opportunity lost? Nat Clin Pract Cardiovasc Med 2007; 4: 610-20.
4. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78: 559S-69.
5. Gonzalez CA, Riboli E. Diet and cancer prevention: where we are, where we are going. Nutr Cancer 2006; 56: 225-31.
6. Crawford M, Galli C, Visioli F, Renaud S, Simopoulos AP, Spector AA. Role of plant-derived omega-3 fatty acids in human nutrition. Ann Nutr Metab 2000; 44: 263-5.
7. Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline, JM, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest 2007; 117: 1866-75.
8. Gago-Dominguez M, Yuan JM, Sun CL, Lee HP, Yu MC. Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study. Br J Cancer 2003; 89: 1686-92.
9. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 2007; 167: 956-65.
10. Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, van den Brandt PA, et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005; 294: 2849-57.
11. Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001; 134: 1106-14.
12. Gillman MW, Cupples LA, Gagnon D, Posner BM, Ellison RC, Castelli WP, et al. Protective effect of fruits and vegetables on development of stroke in men. JAMA 1995; 273: 1113-7.
13. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18: 1-29.
14. Pavia M, Pileggi C, Nobile CG, Angelillo IF. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. Am J Clin Nutr 2006; 83: 1126-34.
15. García-Closas R, García-Closas M, Kogevinas M, Malats N, Silverman D, Serra C, et al. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer 2007; 43: 1731-40.
16. Faramawi MF, Johnson E, Fry MW, Sall M, Zhou Y. Consumption of different types of meat and the risk of renal cancer: meta-analysis of case-control studies. Cancer Causes Control 2007; 18: 125-33.
17. Steinmaus CM, Nuñez S, Smith AH. Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol 2000; 151: 693-702.
18. Polesel J, Talamini R, Montella M, MasoLD, Crovatto M, Parpinel M, et al. Nutrients intake and the risk of hepatocellular carcinoma in Italy. Eur J Cancer 2007; 43: 2381-7.
19. Connelly-Frost A, Poole C, Satia JA, Kupper LL, Millikan RC, Sandler RS. Selenium, apoptosis, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2006; 15: 486-93.
20. Watson WH, Cai J, Jones DP. Diet and Apoptosis. Annu Rev Nutr 2000; 20: 485-505.
21. Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81: 317S-25
22. Nichenametla SN, Taruscio TG, Barney DL, Exon JH. A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 2006; 46: 161-83.
23. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008; 52: 507-26.
24. Lambert JD, Hong J, Yang G, Liao J, Yang CS. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 2005; 81: 284S-91.
25. Fresco P, Borges F, Diniz C, Marques MP. New insights on the anticancer properties of dietary polyphenols. Med Res Rev 2006; 26: 747-66.
26. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM, Venkatachalam MA. Apoptosis: definition, mechanism, and relevance to disease. Am J Med 1999; 107: 489-506.
27. Sun SY, Hail NJr, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 2004; 96: 662-72.
28. Martin KR. Targeting apoptosis with dietary bioactive agents. Exp Biol Med 2006: 231, 117-29.
29. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
30. Kurosaka K, Takahashi M, Watanabe N, Kobayashi Y. Silent cleanup of very early apoptotic cells by macrophages. J Immunol 2003; 171: 4672-9.
31. Elmore, S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.
32. Trump BF, Berezesky IK, Chang SH, Phelps PC. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol 1997; 25: 82-8.
33. Denault JB, Salvesen GS. Caspases: keys in the ignition of cell death. Chem Rev 2002; 102: 4489-500
34. Wang ZB, Liu YQ, Cui YF. Pathways to caspase activation. Cell Biol Int 2005; 29: 489-96.
35. Rai NK, Tripathi K, Sharma D, Shukla VK. Apoptosis: a basic physiologic process in wound healing. Int J Low Extrem Wounds 2005; 4: 138-44.
36. Martinvalet D, Zhu P, Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity 2005; 22: 355-70.
37. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2: 277-88.
38. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501.
39. Rowinsky EK. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol 2005, 23: 9394-407.
40. Mérino D, Lalaoui N, Morizot A, Solary E, Micheau O. TRAIL in cancer therapy: present and future challenges. Expert Opin Ther Targets 2007; 11: 1299-314.
41. Schaefer U, Voloshanenko O, Willen D, Walczak H. TRAIL: a multifunctional cytokine. Front Biosci 2007; 12: 3813-24
42. Falschlehner C, Emmerich CH, Gerlach B, Walczak H. TRAIL signalling: decisions between life and death. In J Biochem Cell Biol 2007; 39: 1462-75.
43. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997; 16: 2794-804.
44. Anguiano-Hernandez YM, Chartier A, Huerta S. Smac/DIABLO and colon cancer. Anticancer Agents Med Chem 2007; 7: 467-73.
45. Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004; 64: 7183-90.
46. Millan A, Huerta S. Apoptosis-Inducing Factor and Colon Cancer. J Surg Res 2009; 151: 163-70.
47. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature, 2001; 410: 549-54.
48. Widlak P, Garrard WT. Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J Cell Biochem 2005; 94: 1078-87.
49. Inohara N, Koseki T, Chen S, Benedict MA, Núnez G. Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD. J Biol Chem 1999; 274: 270-4.
50. Cory S, Adams JM. The Bcl2 family: regulators of the cellular lifeor-death switch. Nat Rev Cancer 2002; 2: 647-56.
51. Thomadaki H, Scorilas A. BCL2 family of apoptosis related genes: functions and clinical implications in cancer. Crit Ver Clin Lab Sci 2006; 43: 1-67.
52. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
53. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993; 53: 4701-14.
54. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-36.
55. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-32.
56. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997; 278: 294-8.
57. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005; 55: 178-194.
58. Benchimol S. p53-dependent pathways of apoptosis. Cell Death Differ 2001; 8: 1049-51.
59. Maldonado V, Meléndez-Zajgla J, Ortega A. Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. Mutat Res 1997; 381: 67-75.
60. Kühnel F, Zender L, Paul Y, Tietze MK, Trautwein C, Manns M, et al. NF-kB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem 2000; 275: 6421-7.
61. Myung J, Kim KB, Crew CM. The ubiquitin-proteasome pathway and proteasome inhibitors. Med Res Rev 2001; 21; 245-73.
62. Adams J, Palombella VJ, Elliot PJ. Proteasome inhibition: a new strategy in cancer treatment. Invest New Drugs 2000; 18: 109-21.
63. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-57.
64. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-26.
65. Wyllie AH, Bellamy CO, Bubb VJ, Clarke AR, Corbet S, Curtis L, et al. Apoptosis and carcinogenesis. Br J Cancer 1999; 80: 34-7.
66. Wyllie A. Apoptosis. Clues in the p53 murder mystery. Nature 1997; 389: 237-238.
67. Reed JC. Dysregulation of apoptosis in cancer. J Clin. Oncol 1999; 17: 2941-53.
68. Zhivotovsky B, Orrenius S. Carcinogenesis and apoptosis: paradigms and paradoxes. Carcinogenesis 2006; 27: 1939-45.
69. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
70. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
71. Hueber AO, Evan GI. Traps to catch unwary oncogenes. Trends Genet 1998; 14: 364-7.
72. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
73. Wright SC, Zhong J, Larrick JW. Inhibition of apoptosis as a mechanism of tumor promotion FASEB J 1994; 8: 654-60.
74. Roth W, Reed JC. Apoptosis and cancer: when BAX is TRAILing away. Nat Med 2002; 8: 216-218.
75. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799-805.
76. Wang XW. Role of p53 and apoptosis in carcinogenesis. Anticancer Res 1999; 19: 4759-71.
77. Bourdon JC. p53 and its isoforms in cancer. Br J Cancer 2007; 97: 277-282.
78. Riboli E, Norat T. Cancer prevention and diet: opportunities in Europe. Public Health Nutr 2001; 4: 475-84.
79. Key TJ, Schatzkin A, Willet WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr 2004; 7: 187-200.
80. Gonzalez CA. Nutrition and Cancer: the current epidemiological evidence. Br J Nutr 2006; 96: S42-S45.
81. Stan SD, Kar S, Stoner G, Singh S. Bioactive food components and cancer risk reduction. J Cell Biochem 2008; 104: 339-56.
82. Hail N Jr. Mitochondria: A novel target for the chemoprevention of cancer. Apoptosis 2005; 10: 687-705.
83. Bouchier-Hayes L, Lartigue L, Newmeyer DD. Mitochondria: pharmacological manipulation of cell death. J Clin Invest 2005; 115: 2640-7.
84. Kelloff GJ, Sigman CC, Greenwald P. Cancer Chemoprevention: Progress and Promise. Eur J Cancer 1999; 35: 2031-8.
85. Kakizoe T. Chemoprevention of cancer - focusing on clinical trials. Jpn J Clin Oncol 2003; 33: 421-42.
86. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, et al. Cancer Chemoprevention: Development of Diet-derived Chemopreventive Agents. J Nutr 2000; 130: 467S-471S.
87. Hail Jr. N, Cortes M, Darke EN, Spalholz JE. Cancer chemoprevention: A radical perspective. Free Rad Biol Med 2008; 45; 97-110.
88. Manach C, Williamson G, Morand C, Sealbert A, Rémésy C. Bioavailability and Bioefficacy of Polyphenols in Humans: I. Review of 97 Bioavailability Studies. Am J Clin Nutr 2005; 81: 230S-242S.
89. Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005; 45: 287-306.
90. Lepley DM, Li B, Birt DF, Pelling JC. The Chemopreventive Flavonoid Apigenin Induces G2/M Arrest in Keratinocytes. Carcinogenesis 1996; 17: 2367-75.
91. Skaper SD, Fabris M, Ferrari V, Carbonare MD, Leon A. Quercetin Protects Cutaneous Tissue-associated Cell Types Including Sensory Neurons from Oxidative Stress Induced by Glutathione Depletion: Cooperative Effects of Ascorbic Acid. Free Radic Biol Med 1997; 22: 669-78.
92. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rémésy C, Chap H, et al. Relationship Between Flavonoid Structure and Inhibition of Phosphatidylinositol-3-kinase and Protein Kinase C Inhibiton. Biochem Pharmacol 1997; 53: 1649-57.
93. Sergediene E, Jonsson K, Szymusiak H, Tyrakowska B, Rietjens ICM, Cenas N. Prooxidant Toxicity of Polyphenolic Antioxidants to HL-60 Cells: Description of Quantitative Structure-activity Relationships. FEBS Lett 1999; 462: 392-6.
94. Yang CS., Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Ann Rev Pharmacol Toxicol 2002; 42: 25-54.
95. Bianco A, Muzzalupo I, Piperno A, Romeo G, Uccella N. Bioactive Derivatives of Oleuropein from Olive Fruits. J Agric Food Chem 1999; 47: 3531-4.
96. Trichopoulou A, Lagiou P, Pappas AM. Mediterranean Diet: Are Antioxidants Central to its benefits? In: Pappas AM Ed, Antioxidant Status, Diet, Nutrition and Health, Boca Raton, Washington CRC Press, 1999; 107-118.
97. Hollman PCH, Katan MB. Dietary Flavonoids: Intake, Health Effects and Bioavailability. Food & Chem Toxicology 1999; 37: 937-42.
98. Bianco A, Uccella N. Biophenolic Components of Olives. Food Res Int 2000; 33: 475-85.
99. Visioli F, Galli C. Biological Properties of Olive Oil Phytochemicals. Crit. Rev. Food Sci Nutr 2002; 42: 209-21.
100. Scalbert A, Williamson G. Dietary Intake and Bioavailability of Polyphenols. J Nutr 2000; 130: 2073S-2085S.
101. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003; 43: 89-143.
102. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74: 418-25.
103. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, et al. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997; 57: 2916-21.
104. Veluri R, Singh RP, Liu Z, Thompson JA, Agarwal R, Agarwal C. Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells. Carcinogenesis 2006; 27: 1445-53.
105. Agarwal C, Tyagi A, Agarwal R. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Mol Cancer Ther 2006; 12: 3294-302.
106. Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A, et al. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res 2004; 6: R63-R74.
107. He YJ, Liu BH, Xiang DB, Qiao ZY, Fu T, He YH. Inhibitory effect of caffeic acid phenethyl ester on the growth of SW480 colorectal tumor cells involves -catenin associated signaling pathway down-regulation. World J Gastroenterol 2006; 21: 4981-5.
108. McEleny K, Coffey R, Morrissey C, Fitzpatrick JM, Watson RW. Caffeic acid phenethyl ester-induced PC-3 cell apoptosis is caspase-dependent and mediated through the loss of inhibitors of apoptosis proteins. BJU Int 2004; 94: 402-6.
109. Balasubramanian S, Eckert RL. Keratinocyte proliferation, differentiation, and apoptosis-differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharmacol 2007; 224: 214-9.
110. Shi M, Cai Q, Yao L, Mao Y, Ming Y. Ouyang G. Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int 2006; 30: 221-6.
111. Singh S, Khar A. Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 2006; 6: 259-70.
112. Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 2005; 5: 117-129.
113. Sa nchez AM, Malagarie-Cazenave S, Olea N, Vara D, Chiloeches A, Di az-Laviada I. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis 2007; 12: 2013-24.
114. Kim YM, Hwang JT, Kwak DW, Lee YK, Park OJ. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann N Y Acad Sci 2007; 1095: 496-503.
115. Morre DM, Morre DJ. Catechin-vanilloid synergies with potential clinical applications in cancer. Rejuvenation Res 2006; 9: 45-55.
116. Hsu S, Singh B, Schuster G. Induction of apoptosis in oral cancer cells: Agents and mechanisms for potential therapy and prevention. Oral Oncol 2004; 40: 461-73.
117. Ishiguro K, Ando T, Maeda O, Ohmiya N, Niwa Y, Kadomatsu K, et al. Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms. Biochem Biophys Res Commun 2007; 362: 218-23.
118. Bode AM, Dong Z. Targeting signal transduction pathways by chemopreventive agents. Mutat Res 2004; 555: 33-51.
119. Keum YS, Kim J, Lee KH, Park, KK, Surh YJ, Lee JM, et al. Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells. Cancer Lett 2002; 177: 41-7.
120. Ragione FD, Cucciolla V, Borriello A, Pietra VD, Pontoni G, Racioppi L, et al. Hydroxytyrosol, a natural molecule occurring in olive oil, induces cytochrome c-dependent apoptosis. Biochem Biophys Res Commun 2000; 278:733-739.
121. Fabiani R, De Bartolomeo A, Rosignoli P, Servili M, Montedoro GF, Morozzi G. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis. Eur J Cancer Prev 2002; 11: 351-8.
122. Wolf I, O'Kelly J, Wakimoto N, Nguyen A, Amblard F, Karlan BY, et al. Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol 2007; 30: 1529-1537.
123. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of NF- B activation pathway. Mol Cancer Res 2006; 4: 621-33.
124. Cecchinato V, Chiaramonte R, Nizzardo M, Cristofaro B, Basile A, Sherbet GV, et al. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem Pharmacol 2007; 74: 1568-74.
125. Van Ginkel PR, Sareen D, Subramanian L, Walker Q, Darjatmoko SR, Lindstrom MJ, et al. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res 2007; 13: 5162-9.
126. Shankar S, Singh G, Srivastava R.K. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 2007; 12: 4839-4854.
127. Gill C, Walsh SE, Morrissey C, Fitzpatrick JM, Watson RW. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate 2007; 67: 1641-53.
128. Lion CJ, Matthews CS, Stevens MFG, Westwell AD. Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes. J Med Chem 2005; 48: 1292-5.
129. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, et al. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF- B. Int J Cancer 2005; 115: 74-84.
130. Pan L, Becker H, Gerhäuser C. Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Mol Nutr Food Res 2005; 49: 837-43.
131. Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kB activation in prostate epithelial cells. Cancer Lett 2007; 246: 201-9.
132. Go ML, Wu X, Liu XL. Chalcones: An update on cytotoxic and chemoprotective properties. Curr Med Chem 2005; 12: 481-499.
133. Nam S, Smith DM, Dou QP. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and bax expression, and induces G1 arrest and apoptosis. Cancer Epidemiol. Biomarkers Prev 2001; 10: 1083-8.
134. Kuo PL, Hsu YL, Lin TC, Tzeng WS, Chen YY, Lin CC. Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting NF- B signaling pathway. Cancer Lett 2007; 248: 280-91.
135. Larrosa M, Toma s-Barbera n FA, Espi n JC. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 2006; 17: 611-25.
136. Kim YH, Lee YJ. TRAIL apoptosis is enhanced by quercetin through akt dephosphorylation. J Cell Biochem 2007; 100: 998-1009.
137. Haghiac M, Walle T. Quercetin induces necrosis and apoptosis in SCC-9 oral cancer cells. Nutr Cancer 2005; 53: 220-31.
138. Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther 2007; 6: 2591-9.
139. Vijayababu MR, Kanagaraj P, Arunkumar A, Ilangovan R, Dharmarajan, A, Arunakaran J. Quercetin induces p53-independent apoptosis in human prostate cancer cells by modulating Bcl-2-related proteins: A possible mediation by IGFBP-3. Oncol Res 2006; 16: 67-74.
140. Granado-Serrano AB, Marti n MA, Bravo L, Goya L, Ramos S. Quercetin induces apoptosis via caspase activation, regulation of bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr 2006; 136: 2715-21.
141. Ma G, Yang C, Qu Y, Wei H, Zhang T, Zhang N. The flavonoid component isorhamnetin in vitro inhibits proliferation and induces apoptosis in Eca-109 cells. Chem Biol Interact 2007; 167: 153-60.
142. Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra MK, Sen E. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol. Cancer Ther 2007; 6: 2544-53.
143. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Sakai T. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol Cancer Ther 2006; 5: 945-51.
144. Khan TH, Sultana S. Apigenin induces apoptosis in hep G2 cells: Possible role of TNF- and IFN- . Toxicology 2006; 217: 206-212.
145. Zhang T, Chen, X, Qu L, Wu J, Cui R, Zhao Y. Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg Med Chem 2004; 12: 6097-105.
146. Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, et al. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: An implication for the antitumor potential of flavonoids. Cancer Res 2006; 66: 4826-34.
147. Ju W, Wang X, Shi H, Chen W, Belinsky SA, Lin Y. A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor- B pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol 2007; 71: 1381-8.
148. Shim HY, Park JH, Paik, HD, Nah SY, Kim DS, Han YS. Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/JNK1/2-c-Jun activation. Mol Cells 2007; 24: 95-104.
149. Kim MJ, Kim DH, Na HK, Oh TY, Shin CY, Surh YJ. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces apoptosis in human gastric cancer (AGS) cells. J Environ Pathol Toxicol Oncol 2005; 24: 261-9.
150. Leung HW, Yang WH, Lai MY, Lin CJ, Lee HZ. Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol 2007; 45: 403-11.
151. Bektic J, Guggenberger R, Eder IE, Pelzer AE, Berger AP, Bartsch G, et al. Molecular effects of the isoflavonoid genistein in prostate cancer. Clin Prostate Cancer 2005; 4: 124-9.
152. Chodon D, Banu SM, Padmavathi R, Sakthisekaran D. Inhibition of cell proliferation and induction of apoptosis by genistein in experimental hepatocellular carcinoma. Mol Cell Biochem 2007; 297: 73-80.
153. Lo FH, Mak NK, Leung KN. Studies on the anti-tumor activities of the soy isoflavone daidzein on murine neuroblastoma cells. Biomed Pharmacother 2007; 61: 591-5.
154. Kumar MA, Nair M, Hema PS, Mohan J, Santhoshkumar TR. Pinocembrin triggers Bax-dependent mitochondrial apoptosis in colon cancer cells. Mol Carcinogenesis 2007; 46: 231-41.
155. Kanno S, Tomizawa A, Ohtake T, Koiwai K, Ujibe M, Ishikawa M. Naringenin-induced apoptosis via activation of NF-κB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett 2006; 166: 131-9.
156. Brunelli E, Minassi A, Appendino G, Moro L. 8-Prenylnaringenin, inhibits estrogen receptor-α mediated cell growth and induces apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 2007; 107: 140-8.
157. Huang WJ, Huang CH, Wu CL, Lin JK, Chen YW, Lin CL, et al. Propolin G, a prenylflavanone, isolated from Taiwanese propolis, induces caspase-dependent apoptosis in brain cancer cells. J Agric Food Chem 2007; 55: 7366-76.
158. Chen CN, Wu CL, Lin JK. Propolin C from propolis induces apoptosis through activating caspases, Bid and cytochrome c release in human melanoma cells. Biochem Pharmacol 2004; 67: 53-66.
159. Chen CN, Wu CL, Lin JK. Apoptosis of human melanoma cells induced by the novel compounds propolin A and propolin B from Taiwenese propolis. Cancer Lett 2007; 245: 218-31.
160. Noda C, He J, Takano T, Tanaka C, Kondo T, Tohyama K, et al. Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells. Biochem Biophys Res Commun 2007; 362: 951-7.
161. Beltz LA, Bayer DK, Moss AL, Simet IM. Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem 2006; 6: 389-406.
162. Kalra N, Seth K, Prasad S, Singh M, Pant AB, Shukla Y. Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kB and mitogen-activated protein kinases pathways. Life Sci 2007; 80: 2137-46.
163. Son YG, Eun HK, Jin YK, Kim SU, Taeg KK, Yoon AR, et al. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Cancer Res 2007; 67: 8274-84.
164. Agarwal C, Tyagi A, Kaur M, Agarwal R. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis 2007; 28: 1463-70.
165. Zhong X, Zhu Y, Lu Q, Zhang J, Ge Z, Zheng S. Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of akt pathway. Toxicology 2006; 227: 211-6.
166. Yeh CT, Yen GC. Induction of apoptosis by the anthocyanidins through regulation of Bcl-2 gene and activation of c-Jun N-terminal kinase cascade in hepatoma cells. J Agric Food Chem 2005; 53: 1740-1749.
167. Srivastava A, Akoh CC, Fischer J, Krewer G. Effect of anthocyanin fractions from selected cultivars of Georgia-grown blueberries on apoptosis and phase II enzymes. J Agric Food Chem 2007; 55: 3180-5.
168. Hou DX. Potential mechanisms of cancer chemoprevention by anthocyanins. Curr Mol Med 2003; 3: 149-59.
169. Borges F, Roleira F, Milhazes N, Santana L, Uriarte E. Simple coumarins and analogues in medicinal chemistry: Occurrence, synthesis and biological activity. Curr Med Chem 2005; 12: 887-916.
170. Jun DY, Kim JS, Park HS, Han CR, Fang Z, Woo MH, et al. Apoptogenic activity of auraptene of Zanthoxylum schinifolium toward human acute leukemia Jurkat T cells is associated with ER stress-mediated caspase-8 activation that stimulates mitochondria-dependent or -independent caspase cascade. Carcinogenesis 2007; 28: 1303-13.
171. Goel A, Prasad AK, Parmar VS, Ghosh B, Saini N. 7,8-Dihydroxy-4- methylcoumarin induces apoptosis of human lung adenocarcinoma cells by ROS-independent mitochondrial pathway through partial inhibition of ERK/MAPK signalling. FEBS Lett 2007; 581:2447-54.
172. Kang K, Lee HJ, Kim CY, Lee SB, Tunsag J, Batsuren D, et al. The chemopreventive effects of Saussurea salicifolia through induction of apoptosis and phase II detoxification enzyme. Biol Pharm Bull 2007; 30: 2352-9.
173. Shashi B, Jaswant S, Madhusudana RJ, Kumar SA, Nabi QG. A novel lignan composition from Cedrus deodara induces apoptosis and early nitric oxide generation in human leukemia Molt-4 and HL-60 cells. Nitric Oxide 2006; 14: 72-88.
174. Webb AL, McCullough ML. Dietary lignans: Potential role in cancer prevention. Nutr Cancer 2005; 51: 117-31.
175. Mertens-Talcott SU, Lee JH, Percival SS, Talcott ST. Induction of cell death in Caco-2 human colon carcinoma cells by ellagic acid rich fractions from muscadine grapes (Vitis rotundifolia). J Agric Food Chem 2006; 54: 5336-43.
176. Taraphdar AK, Roy M, Bhattacharya RK. Natural products as inducers of apoptosis: implication for cancer therapy and prevention. Nutr Cancer 2005; 53: 220-31.
177. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007; 18: 427-42.
178. Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. EGCG Down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol 2004; 24: 703-10.
179. Kuo PL, Hsu YL, Sung SC, Ni WC, Lin TC, Lin CC. Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by Pterocarnin A from the bark of Pterocarya Stenoptera via the Fas-mediated pathway. Anti-Cancer Drugs 2007; 18: 555-62.
180. Shen S, Chen Y, Hsu F, Lee W. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase-3 cascade. J Cell Biochem 2003; 89: 1044-1055.
181. Chen D, Daniel K, Chen M, Kuhn D, Landis-Piwoear K, Dou Q. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukaemia cells. Biochem Pharmacol 2005; 69: 1421-32.
182. Choi JA, Kim JY, Lee JY, Kang CM, Kwon JH. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol 2001; 19: 837-44.
183. Dechsupa S. Quercetin, siamois 1 and siamois 2 induce apoptosis in human breast cancer MDA-MB-435 cells xenograft in vivo. Cancer Biol Ther 2007; 6: 56-61.
184. Nguyen T, Tran E, Do P, Huynh T, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 2004; 25: 647-59.
185. Huynh H, Nguyen T, Cahn E, Tran E. Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha) and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation. Int J Oncol 2003; 23: 821-9.
186. Vijayababu M, Kanagaraj P, Arunkumar A, Ilangovan R, Aruldhas M, Arunakaran J. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol 2005; 131: 765-71.
187. Van Erik M, Roepman P, van der Lende T, Stierum R, Aarts J, Van Bladeren P. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr 2005; 44: 143-56.
188. Al-Ayyoubi S. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status. Mol Carcinogenesis 2007; 46: 176-86.
189. Stewart JR, Artime MC, O'Brian CA. Resveratrol: a candidate nutritional substance for prostate cancer prevention. J Nutr 2003; 133: 2440S-3S.
190. Xu J, Loo G. Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines. J Cell Biochem 2001; 82: 78-88.
191. Li Y, Upadhyay S, Bhuiyan M, Sarkar F. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 1999; 18: 3166-72.
192. Kumi-Diaka J, Sanderson NA, Hall A. The mediating role of caspase-3 protease in the intracellular mechanism of genisteininduced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP. Biol Cell 2000; 92: 595-604.
193. Li Y, Sarkar F. Inhibition of NF-kB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 2002; 8: 2369-77.
194. Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cells lines established from the gastrointestinal tract. Cancer Res 1993; 53: 5815-21.
195. Lian F, Li Y, Bhuiyan M, Sarkar F. p53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer 1999; 33: 125-31.
196. Alhasan S, Ensley J, Sarkar F. Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int J Oncol 2000; 16: 333-8.
197. Alhasan S, Pietrasezkiwicz H, Alonso M, Ensley J, Sarkar F. Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr Cancer 1999; 34: 12-9.
198. Achiwa Y, Hibasami H, Katsuzaki H, Imai K, Komiya T. Inhibitory effects of Persimmon (Diospyros kaki) extract and related polyphenol compounds on growth of human lymphoid leukemia cells. Biosci Biotechnol Biochem 1997; 61: 1099-1101.
199. Kountouri AM, Kaliora AC, Koumbi, L, Andrikopoulos NK. Invitro gastric cancer prevention by a polyphenol-rich extract from olives through induction of apoptosis. Eur J Cancer Prev 2009; 18: 33-9.
200. Mouria M, Gukovskaya A, Jung Y, Buechler P, Hines O, Reber H. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome c release and apoptosis. Int J Cancer 2002; 98: 761-69.
201. Ramos S, Alia M, Bravo L, Goya L. Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem 2005; 53: 1271-80.
202. Galati G, Teng S, Moridani MY, Chang TS, O'Brien PJ. Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenols. Drug Metab Drug Interact 2000; 17: 311-49.
203. Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA, et al. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res 2007; 67: 8396-8405.
204. Kaur M, Singh RP, Gu M, Agarwal R, Agarwal C. Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells. Clin. Cancer Res 2006; 12: 6194-202.
205. Kaur M, Agarwal R, Agarwal C. Grape seed extract induces anoikis and caspase-mediated apoptosis in human prostate carcinoma LNCaP cells: Possible role of ataxia telangiectasia mutated-p53 activation. Mol Cancer Ther 2006; 5: 1265-1274.
206. Kim MJ, Kim YJ, Park HJ, Chung JH, Leem KH, Kim HK. Apoptotic effect of red wine polyphenols on human colon cancer SNU-C4 cells. Food Chem Toxicol 2006; 44: 898-902.
207. Raina K, Singh, RP, Agarwal R, Agarwal C. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice. Cancer Res 2007; 67: 5976-82.
208. Tedesco I, Nappo A, Petitto F, Iacomino G, Nazzaro F, Palumbo R, et al. Antioxidant and cytotoxic properties of lyophilized beer extracts on HL-60 cell line. Nutr Cancer 2005; 52: 74-83.
209. Seeram NP, Adams LS, Zhang Y, Lee R, Sand D, Scheuller HS, et al. Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric. Food Chem 2006; 54: 9329-39.
210. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 2005; 102: 14813-8.
211. Fujii T, Ikami T, Xu JW, Ikeda K. Prune extract (Prunus domestica L.) suppresses the proliferation and induces the apoptosis of human colon carcinoma caco-2. J Nutr Sci Vitaminol (Tokyo) 2006; 52: 389-91.
212. Ding H, Chin YW, Kinghorn AD, D'Ambrosio SM. Chemopreventive characteristics of avocado fruit. Semin Cancer Biol 2007; 17: 386-94.
213. Saha P, Banerjee S, Ganguly C, Manna S, Panda CK, Das S. Black tea extract can modulate protein expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary hyperplasia, dysplasia, and carcinoma in situ. J Environ Pathol Toxicol Oncol 2005; 24: 211-24.
214. Bhattacharyya A, Lahiry L, Mandal D, Sa G, Das T. Black tea induces tumor cell apoptosis by Bax translocation, loss in mitochondrial transmembrane potential, cytochrome c release and caspase activation. Int J Cancer 2005; 117: 308-15.
215. Srivastava JK, Gupta S. Antiproliferative and apoptotic effects of chamomile extract in various human cancer cells. J Agric Food Chem 2007; 55: 9470-8.
216. Conney AH, Zhou S, Lee MJ, Xie JG, Yang CS, Lou YR, et al. Stimulatory effect of oral administration of tea, coffee or caffeine on UVB-induced apoptosis in the epidermis of SKH-1 mice. Toxicol Appl Pharmacol 2007; 224: 209-13.
217. Scifo C, Milasi A, Guarnera A., Sinatra F, Renis M. Resveratrol and propolis extract: An insight into the morphological and molecular changes induced in DU145 cells. Oncol Res 2006; 15: 409-21.
218. Cai H, Hudson EA, Mann P, Verschoyle RD, Greaves P, Manson MM, et al. Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo. Br J Cancer 2004; 91: 1364-71.
219. Vijaya Padma V, Arul Diana Christie S, Ramkuma KM. Induction of apoptosis by ginger in HEp-2 cell line is mediated by reactive oxygen species. Basic Clin Pharmacol Toxicol 2007; 100: 302-7.
220. Sebastian KS, Thampan RV. Differential effects of soybean and fenugreek extracts on the growth of MCF-7 cells. Chem Biol Interact 2007; 170: 135-43.
221. Juan ME, Wenzel U, Ruiz-Gutierrez V, Daniel H, Planas JM. Olive fruit extracts inhibit proliferation and induce apoptosis in HT-29 human colon cancer cells. J Nutr 2006; 136: 2553-7.
222. Fabiani R, De Bartolomeo A, Rosignoli P, Servili M, Selvaggini R, Montedoro GF, et al. Virgin olive oil phenols inhibit proliferation of human promyelocytic leukemia cells (HL60) by inducing apoptosis and differentiation. J Nutr 2006; 136: 614-9.
223. Sacco SM, Power KA, Chen J, Ward WE, Thompson LU. Interaction of sesame seed and tamoxifen on tumor growth and bone health in athymic mice. Exp Biol Med 2007; 232: 754-61.
224. Reddivari L, Vanamala J, Chintharlapalli S, Safe SH, Miller Jr JC. Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways. Carcinogenesis 2007; 28: 2227-2235.
225. Sarkar FH, Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 2006; 66: 3347-50.
226. Chan M, Fong D, Soprano K, Holmes W, Heverling H. Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol 2003; 194: 63-70.
227. Khafif, A, Schantz, S, Chou, T, Edelstein, D, Sacks, P. Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 1998; 19: 419-24.
228. Mertens-Talcott S, Percival S. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 2005; 218: 141-51.
229. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H. Synergistic effects of ( - )-epigallocatechin gallate with ( - )-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 1999: 59, 44-7.
230. Sharma H, Sen S, Singh N. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer Cancer Biol Ther 2005; 4: 949-55.
231. Jakubowicz-Gil J, Paduch R, Piersiak T, Glowniak K, Gawron A, Kandefer-Szerszen M. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochem Pharmacol 2003; 69: 1343-50.
232. Hwang JT, Ha J, Park O. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 2005; 332: 433-40.
233. Pezzuto JM. Plant-derived anticancer agents. Biochem Pharmacol 1997; 53: 121-33.
234. Passi S, Picardo M, Nazarro-Porro M. Comparative cytotoxicity of phenols in vitro. Biochem J 1987; 245: 537-42.
235. Moridani MY, Galati G, O'Brien PJ. Comparative quantitative structure toxicity relationships for flavonoids evaluated in isolated rat hepatocytes and HeLa tumor cells. Chem Biol Interact 2002; 139: 251-64.
236. Siraki A, Chan TS, O'Brien PJ. Application of quantitative structure-toxicity relationships for the comparison of the cytotoxicity of 14 p-benzoquinone congeners in primary cultured rat hepatocytes versus PC12 cells. Toxicol Sci 2004; 81: 148-59.
237. Depeint F, Gee JM, Williamson G, Johnson IT. Evidence for consistent patterns between flavonoid structures and cellular activities. Proc Nutr Soc 2002; 61: 97-103.
238. Gomes CA, Girão da Cruz, T, Andrade JL, Milhazes N, Borges F, Marques MPM. Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study. J Med Chem 2003; 46: 5395-401.
239. van Besien E, Marques MPM. Ab initio conformational study of caffeic acid. J Molec Struct (THEOCHEM) 2003; 625: 265-75.
240. Fiuza, S.M, Van Besien, E, Milhazes, N, Borges, F, Marques, MPM. Conformational analysis of a trihydroxylated derivative of cinnamic acid - a combined Raman spectroscopy and Ab initio study. J Mol Struct 2004; 693:103-18.
241. Calheiros, R, Milhazes, N, Borges, F, Marques, MPM. β-Nitrostyrene derivatives - a conformational study by combined Raman spectroscopy and ab initio MO calculations. J Mol Struct 2004; 692: 91-106.
242. Fiuza SM, Gomes C, Teixeira LJ. Girão da Cruz MT. Cordeiro MN, Milhazes N, et al. Phenolic acid derivatives with potential anticancer properties - a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids. Bioorg Med Chem 2004; 12: 3581-9.
243. Teixeira S, Siquet C, Alves C, Boal I, Marques MPM, Borges F, et al. Structure-property studies on the antioxidant activity of flavonoids present in diet. Free Radic Biol Med 2005; 39: 1099-108.
244. Milhazes N, Calheiros R, Marques MPM, Garrido J, Cordeiro MNDS, Rodrigues C, et al. Beta-nitrostyrene derivatives as potential antibacterial agents: a structure-property-activity relationship study. Bioorg Med Chem 2006; 14: 4078-88.
245. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996; 20: 933-56.
246. Phan TT, Wang L, Grayer RJ, Chan SY, Lee ST. Phenolic compounds of Chromolaena odorata protect cultured skin cells from oxidative damage: implication for cutaneous wound healing. Biol Pharm Bull 2001; 24: 1373-9.
247. Esteves M, Siquet C, Gaspar A, Rio V, Sousa J, Reis S, et al. Antioxidant versus cytotoxic properties of hydroxycinnamic acid derivatives - a new paradigm in phenolic research. Arch Pharm 2008; 341: 64-73.
248. Aruoma O, Murcia A, Butler J, Halliwell B. Evaluation of the antioxidant and prooxidant actions of gallic acid and its derivatives. J Agric Food Chem 1993; 41: 1880-5.
249. Li Y, Trush M. Reactive oxygen-dependent DNA damage resulting from the oxidation of phenolic compounds by a copper-redox cycle mechanism. Cancer Res 1994; 54: 1895-8.
250. Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 1997; 22: 749-60.
251. Galati G, Sabzevari O, Wilson JX, O'Brien PJ. Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 2002; 177: 91-104.
252. Khan NS, Ahmad A, Hadi SM. Anti-oxidant, pro-oxidant properties of tannic acid and its binding to DNA. Chemicobiol Interact 2000; 125: 177-189.
253. Serini S, Piccioni E, Merendino N, Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis 2009; 14: 135-52.
254. Herman-Antosiewicz A, Singh S. Signal transduction pathways leading to cell arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutat Res 2004; 555: 121-31.
255. Palozza P. Sestito R, Picci N, Lanza P, Monego G, Ranelletti FO. The sensitivity of -carotene growth-inhibitory and pro-apoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells. Carcinogenesis 2008; 11: 2153-61.
256. Constantinou C, Papas A, Constantinou I. Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer 2008; 123:739-52.
257. Guan L, Han B, Li Z, Fangyuan H, Huang F, Wei W, et al. Sodium selenite induces apoptosis by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in human acute promyelocytic leukemia NB4 cells. Apoptosis 2009; 14: 218-25.
258. Hong S-W, Jin D-H, Hahm E-S, Yim S-H, Lim J-S, Kim K-I, et al. Ascorbate (vitamin C) induces cell death through the apoptosis-inducig factor in human breast cancer cells. Mutat Res 2004; 555: 121-31.
259. Hwang ES, Bowen PE. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food 2004; 7: 284-289.
260. Kim HS, Bowen P, Chen L, Duncan C, Ghosh L, Sharifi R, et al. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer 2003; 47: 40-7.
261. Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther 2004; 3: 333-41.
262. Fields AL, Soprano DR, Soprano KJ. Retinoids in biological control and cancer. J Cell Biochem 2007; 102: 886-98.
263. Gosslau A, Chen KY. Nutraceuticals, apoptosis, and disease prevention. Nutrition 2004; 20: 95-102.
264. Cheung E, Wadhera P, Dorff T, Pinski J. Diet and prostate cancer risk reduction. Expert Rev Anticancer Ther 2008; 8:43-50.
265. Velmurugan B, Mani A, Nagini S. Combination of S-allylcysteine and lycopene induces apoptosis by modulating Bcl-2, Bax, Bim and caspases during experimental gastric carcinogenesis. Eur J Cancer Prev 2005; 14: 387-93.
266. Fimognari C, Nüsse M, Berti F, Iori R, Cantelli-Forti G, Hrelia P. Isothiocyanates as novel cytotoxic and cytostatic agents: molecular pathway on human transformed and non-transformed cells Biochem Pharmacol 2004; 15: 1133-8.
267. Fimognari C, Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Mutat Res 2007; 635: 90-104.
268. Gingras D, Gendron M, Boivin D, Moghrabi A, Théorêt Y, Be liveau R. Induction of medulloblastoma cell apoptosis by sulforaphane, a dietary anticarcinogen from Brassica vegetables. Cancer Lett 2004; 203: 35-43.
269. Moiseeva EP, Almeida GM, Jones GD, Manson MM. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol Cancer Ther 2007; 6: 3071-9.
270. Mezencev R, Mojzis J, Pila tova M, Kutschy P. Antiproliferative and cancer chemopreventive activity of phytoalexins: Focus on indole phytoalexins from crucifers. Neoplasma 2003; 50: 239-45.
271. Rogan EG. The natural chemopreventive compound indole-3-carbinol: State of the science. In Vivo 2006; 20: 221-8.
272. Neuzil J, Dong LF, Ramanathapuram L, Hahn T, Chladova M, Wang XF, et al. Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. Mol Aspects Med 2007; 28: 607-45.
273. Nesaretnam K, Wong WY, Wahid MB. Alpha-tocopheryl phosphate is a novel apoptotic agent. Eur J Lipid Sci Technol 2007; 109: 445-52.
274. Ogawa M, Nakai S, Deguchi A, Nonomura T, Masaki T, Uchida N, et al. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int J Oncol 2007; 31: 323-31.
275. Rooprai HK, Kyriazis I, Nuttall RK, Edwards DR, Zicha D, Aubyn D, et al. Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol 2007; 30: 1263-71.
276. Keck AS, Finley JW. Cruciferous Vegetables: Cancer Protective Mechanisms of Glucosinolate Hydrolysis Products and Selenium. Integr Cancer Ther 2004; 3: 5-12.
277. Aboul-Fadl T. Selenium derivatives as cancer preventive agents. Curr Med Chem Anticancer Agents 2005; 5: 637-52.
278. Young GP, Hu Y, Le Leu RK, Nyskohus L. Dietary fibre and colorectal cancer: A model for environment - Gene interactions. Mol Nutr Food Res 2005; 49: 571-84.
279. Edris AE. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytother Res 2007; 21: 308-323.
280. Dudai N, Weinstein Y, Krup M, Rabinski T, Ofir R. Citral is a new inducer of caspase-3 in tumor cell lines. Planta Med 2005; 71: 484-8.
281. Raghuvar Gopal DV, Narkar AA, Badrinath Y, Mishra KP, Joshi DS. Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl. Toxicol Lett 2005; 155: 343-51.
282. Yeruva L, Pierre KJ, Elegbede A, Wang RC, Carper SW. Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. Cancer Lett 2007; 257: 216-226.
283. Harmand PO, Duval R, Delage C, Simon A. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int J Cancer 2005; 114: 1-11.
284. Shidoji Y, Ogawa H. Natural occurrence of cancer-preventive geranylgeranoic acid in medicinal herbs. J Lipid Res 2004; 45: 1092-1103.
285. Joo JH, Liao G, Collins JB, Grissom SF, Jetten AM. Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response. Cancer Res 2007; 67: 7929-36.
286. Bode AM, Dong Z. The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 2007; 247: 26-39.
287. Malki AM, Gentry J, Evans SC. Differential effect of selected methylxanthine derivatives on radiosensitization of lung carcinoma cells. Exp Oncol 2006, 28, 16-24.
288. Shiu LY, Chang LC, Liang CH, Huang YS, Sheu HM, Kuo KW. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin. Food Chem Toxicol 2007; 45: 2155-64.
289. Zhu T, Guo J, Collins L, Kelly J, Xiao ZJ, Kim SH, et al. Phellinus linteus activates different pathways to induce apoptosis in prostate cancer cells. Br J Cancer 2007; 96: 583-90.
290. Lavi I, Friesem D, Geresh S, Hadar Y, Schwartz B. Cell-cycle arrest and apoptosis induction in human breast carcinoma MCF-7 cells by carboxymethylated -glucan from the mushroom sclerotia of Pleurotus tuber-regium. Cancer Lett 2006; 244: 61-70.
291. Lavi I, Friesem D, Geresh S, Hadar Y, Schwartz B. An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells. Carbohydr Polymer 2006; 66: 455-62.
292. Hasegawa M, Yagi K, Iwakawa S, Hirai M. Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells. Jpn J Cancer Res 2001; 92:459-466.
293. Calviello G, Serini S, Piccioni E. Omega-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr Med Chem 2007; 14: 3059-69.
294. Narayan B, Hosokawa M, Yasui Y, Suzuki R, Kohno H, Tanaka T, Miyashita K. Chemopreventive effects of conjugated linolenic acids (CLN) occurring in plant seed oils. Curr Nutr Food Sci 2007; 3: 309-18.
295. Kato T, Kolenic N, Pardini RS. Docosahexaenoic Acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr Cancer 2007; 58: 178-87.
296. Courtney ED, Matthews S, Finlayson C, Pierro D, Belluzzi A, Roda E, et al. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 2007; 22: 765-76.
297. Parodi PW. A role for milk proteins and their peptides in cancer prevention. Curr Pharm Des 2007; 13: 813-28.
298. Mohan KV, Gunasekaran P, Varalakshmi E, Hara Y, Nagini S. In vitro evaluation of the anticancer effect of lactoferrin and tea polyphenol combination on oral carcinoma cells. Cell Biol Int 2007; 31: 599-608.
299. Reed JC. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 2001; 7: 314-9.
300. Willett WC. Diet, nutrition, and avoidable cancer. Environ Health Perspect 1995; 103: 165-70.
301. Zhou B, Zhong-Li L. Bioantioxidants: From chemistry to biology. Pure Appl Chem 2005; 77: 1887-1903.
302. Manson MM, Farmer PB, Gescher A, Steward WP. Innovative agents in cancer prevention. Recent Results Cancer Res 2005; 166: 257-75.
303. Aruoma OI. Nutrition and health aspects of free radicals and antioxidants. Chem Toxicol 1994; 32: 671-83.
304. Hercberg S. The history of beta-carotene and cancers: from observational to intervention studies. What lessons can be drawn for future research on polyphenols? Am J Clin Nutr 2005; 81: 223S-9S.
305. Magrone T, Candore G, Caruso C, Jirillo E, Covelli V. Polyphenols from red wine modulate immune responsiveness: biological and clinical significance. Curr Pharm Des 2008; 14(26): 2733-48.
306. Magrone T, Panaro MA, Jirillo E, Covelli V. Molecular effects elicited in vitro by red wine on human healthy peripheral blood mononuclear cells: potential therapeutical application of polyphenols to diet-related chronic diseases. Curr Pharm Des 2008; 14(26): 2758-66.
307. Magrone T, Tafaro A, Jirillo F, Amati L, Jirillo E, Covelli V. Elicitation of immune responsiveness against antigenic challenge in age-related diseases: effects of red wine polyphenols. Curr Pharm Des 2008; 14(26): 2749-57.